Assessment of Myocardial Fibrosis Using Multimodality Imaging in Heart Failure

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047438

Enrollment

Unknown

Registered

2021-06-18

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Left ventricular ejection fraction (LVEF) 1; 4.After optimized treatment (medicine, assistive device treatment), symptoms such as dyspnea and/or fatigue still occur at rest or with minimal physical activity.

Exclusion criteria

Exclusion criteria: 1. Poor image quality; 2. CMR contraindications.

Design outcomes

Primary

Measure	Time frame
strain;native T1;Myocardial Fibrosis;	—

Countries

China

Contacts

Public ContactLi Yuman

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

liym@hust.edu.cn+86 18986067682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026